
Arsenal Capital Partners acquires model-based drug development company Certara
Private equity firm Arsenal Capital Partners has acquired Certara, a provider of model-based drug development and data analytics software and consulting services to the biopharmaceutical research and development market. Certara provides highly specialised and integrated solutions which consist of computer-based models supported by scientific consulting services and which span the

